Comment

  • 7 June 2017

    Opportunities for Abemaciclib in the future?

    On June 3, the results of the MONARCH 2 Phase III trial were presented at the American Society of Clinical Oncology (ASCO) conference, showing a benefit in Progression Free Survival...

Go Top